Yet Another Disease Is Attacking Tasmanian Devils

Oh, great. As if the communicable cancer already wiping out the species weren’t bad enough

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American


Tasmanian devils (Sarcophilus harrisii) just can’t catch a break. The infamous Australian carnivores have already been nearly wiped out by an incurable communicable cancer called devil facial tumor disease (DFTD), which first appeared in 1996 and has since killed as much as 90 percent of the entire species. As if that weren’t bad enough—and it’s pretty awful—now we have word that another disease has appeared on the horizon.

This time around it’s a bacterial infection called leptospirosis, which is often fatal in both humans and wildlife if left untreated. Leptospirosis—caused by a genus of spiral-shaped bacteria called Leptospira—has been seen in Australia before but never in Tasmanian devils. Early symptoms of the infection (which vary by species of bacteria and host) include headaches and nausea. Later, much more severe symptoms can include bleeding in the lungs and meningitis. The infection can usually be knocked out by antibiotics, although it can leave behind permanent liver or kidney damage.

The presence of the bacteria in the marsupials was uncovered by Sarah Wynwood, a PhD student at the University of the Sunshine Coast in Queensland, who earlier this year developed the first new test to diagnose the bacteria in more than a century.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


A native of Tasmania, Wynwood recently conducted leptospirosis tests on her state’s iconic devils—for which she says she has “a soft spot”—to see if any factors besides DFTD may be contributing to their decline. She tested samples from 83 animals and, using multiple testing methodologies, found leptospirosis antibodies in 11 of them.

Not only did she find the bacteria, she discovered a new strain that had never before been observed.

Wynwood says the devil tissue samples came from a wide range of locations, so the bacteria did not appear to be limited to any specific region or location.

The discovery supports earlier theories that a co-infection could be weakening Tasmanian devils’ ability to fend off the deadly cancer. So far, however, there’s no obvious link between DFTD and the Leptospira pathogen, but Wynwood says that’s the focus of the next phase of her research.

Will this new bacterial research actually yield another possible avenue toward protecting Tasmanian devils before DFTD wipes them all out? It’s too early to say, but at this stage any hope or new research path is all we’ve got.

Photo by James Stewart. Used under Creative Commons license

Previously in Extinction Countdown:

John R. Platt is the editor of The Revelator. An award-winning environmental journalist, his work has appeared in Scientific American, Audubon, Motherboard, and numerous other magazines and publications. His "Extinction Countdown" column has run continuously since 2004 and has covered news and science related to more than 1,000 endangered species. John lives on the outskirts of Portland, Ore., where he finds himself surrounded by animals and cartoonists.

More by John R. Platt

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe